Effects of lithium and carbamazepine on thyroid hormone metabolism in rat brain

Neuropsychopharmacology

Volumn 16, Issue 1, 1997, Pages 25-41

  Baumgartner, Andreas ^a   Pinna, Graziano ^a   Hiedra, Luis ^a   Gaio, Ursula ^a   Hessenius, Carsten ^a   Campos Barros, Angel ^a   Eravci, Murat ^a   Prengel, Hans ^a   Thoma, Rudy ^a   Meinhold, Harald ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Carbamazepine; Deiodinases; Lithium; Rat brain; Thyroid hormones

Indexed keywords

CARBAMAZEPINE; LITHIUM; THYROID HORMONE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; DRUG BLOOD LEVEL; ISOTOPE LABELING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THYROID HORMONE METABOLISM;

EID: 17544394692     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(96)00144-3     Document Type: Article

References (95)

1. Atack JR, Prior AM, Griffith D, Ragan CI (1993): Characterization of the effects of lithium on phosphatidylinositol (PI) activity in human muscarinic (m1) receptor-transfected CHO cells. Br J Pharmacol 110:809-815
2. Atterwill CK (1981): Effect of acute and chronic tri-iodothyronine (T3) administration to rats on central 5-HT and dopamin-mediated behavioural responses and related brain biochemistry. Neuropharmacology 20:131-144
3. Atterwill CK, Atkinson DJ, Bermudez I, Balazs R (1985): Effect of thyroid hormone and serum on the development of Na+,K+-adenosine triphosphatase and associated ion fluxes in cultures from rat brain. Neuroscience 14:361-373
4. Avissar S, Schreiber G, Danon A, Belmaker RH (1988): Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 331:440-442
5. Avissar S, Schreiber G (1989): Muscarinic receptor subclassification and G-proteins: Significance for lithium action in affective disorders and for the treatment of the extrapyramidal side effects of neuroleptics. Biol Psychiatry 26:113-130
6. Avissar S, Schreiber G (1990): Carbamazepine and electroconvulsive shock attenuate β-adrenoceptor and muscarinic cholinoceptor coupling to G proteins in rat cortex. Eur J Pharmacol 189:89-103
7. Balsam A, Ingbar SH (1978): The influence of fasting, diabetes, and several pharmacological agents on the pathways of thyroxine metabolism in rat liver. J Clin Invest 21:415-424
8. Bauer MS, Whybrow PC (1990): Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: A preliminary study. Arch Gen Psychiatry 47:435-440
9. Baumgartner A, Dubeyko M, Campos-Barros A, Eravci M, Meinhold H (1994a): Subchronic administration of fluoxetine to rats affects triiodothyronine production and deiodination in regions of the cortex and in the limbic forebrain. Brain Res 635:68-74
10. Baumgartner A, Campos-Barros A, Gaio U, Hessenius C, Frege I, Meinhold H (1994b): Effects of lithium on thyroid hormone metabolism in rat frontal cortex. Biol Psychiatry 36:771-774
11. Baumgartner A, Campos-Barros A, Gaio U, Hessenius C, Flechner A, Meinhold H (1994c): Carbamazepine affects triiodothyronine production and metabolization in rat hippocampus. Life Sci 54:PL401-407
12. Baumgartner A, Bauer M, Hellweg R (1994d): Treatment of intractable non-rapid cycling bipolar affective disorder with high-dose thyroxine: An open clinical trial. Neuropsychopharmacology 10:183-189
13. Baumgartner A, von Stuckrad M, Müller-Oerlinghausen B, Gr̈f K-J, Kürten I (1995): The hypothalamic-pituitarythyroid axis in patients maintained on lithium prophylaxis for years: High triiodothyronine serum concentrations are correlated to the prophylactic efficacy. J Affective Disord 34:211-218
14. Bentsen KD, Gram L, Veje A (1983): Serum thyroid hormones and blood folic acid during monotherapy with Carbamazepine or valproate. A controlled study. Acta Neurol Scand 67:235-241
15. 3) binding to nuclei from rat cerebral hemispheres. Biol Psychiatry 37:106-111
16. Bradford MM (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
17. Bunney WE, Garland-Bunney BL (1987): Mechanism of action of lithium in affective illness: Basic and clinical implications. In Meltzer HY (ed.), Psychopharmacology. New York, Raven Press, pp. 553-565
18. Calabrese JR, Bowden C, Woyshville MJ (1994): Lithium and the anticonvulsants in the treatment of bipolar disorder. In Bloom FE, Kupfer DJ (eds), Psychopharmacology. The Fourth Generation of Progress. New York, Raven Press, pp 1099-1112
19. Campos-Barros A, Baumgartner A (1994): Effects of chronic desipramine treatment of thyroid hormone concentrations in rat brain: Dependency on drug dose and brain area. Biol Psychiatry 35:214-216
20. Campos-Barros A, Köhler R, Müller F, Eravci M, Meinhold H, Wesemann W, Baumgartner A (1993): The influence of sleep deprivation on thyroid hormone metabolism in rat frontal cortex. Neurosci Lett 162:145-148
21. Campos-Barros A, Meinhold H, Stula M, Müller F, Köhler R, Eravci M, Putzien O, Baumgartner A (1994): The influence of desipramine on thyroid hormone metabolism in rat brain. J Pharmacol Exp Ther 268:1143-1152
22. Campos-Barros A, Meinhold H, Köhler R, Müller F, Eravci M, Baumgartner A (1995): The effects of desipramine on thyroid hormone concentrations in rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 353:469-474
23. Campos-Barros A, Höll T, Stoltenburg G, Musa A, Pinna G, Eravci M, Meinhold H, Baumgartner A (1996): Phenolic and tyrosyl ring iodothyronine deiodination and thyroid hormone concentrations in the human central nervous system. J Clin Endocrinol Metab 81:2179-2185
24. Cameron OG, Smith CB (1980): Comparison of acute and chronic lithium treatment on 3H-norepinephrine uptake by rat brain slices. Psychopharmacology 67:81-85
25. Carli M, Anand-Srivastava MB, Molina-Holgado E, Dewar KM, Reader TA (1994): Effects of chronic lithium treatments on dopaminergic receptor systems: G proteins as possible targets. Neurochem Int 24:13-22
26. 3 in diphenylhydantoin-treated patients. Metabolism 28(11):1161-1165
27. Connell JMC, Rapeport WG, Gordon S, Brodie MJ (1984): Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazepine. Eur J Clin Pharmacol 26:453-456
28. Courtin F, Chantoux F, Pierre M, Francon J (1988): Induction of Type II 5'-deiodinase activity cyclic adenosine 3',5'monophosphate in cultured rat astroglial cell. Endocrinology 123:1577-1581
29. Courtin F, Chantoux F, Gavaret J-M, Toru-Delbauffe D, Jacquemin C, Pierre M (1989): Induction of type II5′deiodinase activity in cultured rat astroglial cells by 12-O-tetradecanoylphorbol-12-acetate: Dependence on glucocorticoids. Endocrinology 125:1277-1281
30. Courtin F, Liva P, Gavaret JM, Toru-Delbauffe D, Pierre M (1991): Induction of 5-deiodinase activity in astroglial cells by 12-O-tetradecanoylphorbol 12-acetate and fibroblast growth factors. J Neurochem 56:1107-1132
31. Crantz FR, Silva JE, Larsen PR (1982): Analysis of the sources and quantity of 3,5,3'-iodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology 110:367-375
32. Davey JC, Becker KB, Schneider MJ, St. Germain DL, Galton VA (1995): Cloning of a cDNA for the type II iodothyronine deoidinase. J Biol Chem 270:26786-26789
33. Dixon JE, Lee CH, Los GV, Hokin LE (1992): Lithium enhances accumulation of [3H]inositol radioactivity and mass of second messenger inositol 1,4,5-trisphosphate in monkey cerebral cortex slices. J Neurochem 59:2332-2335
34. Eelkman-Rooda SJ, Otten MH, van Loon MAC, Kaptein E, Visser TJ (1989): Metabolism of triiodothyronine in rat hepatocytes. Endocrinology 125:2187-2192
35. Ellis J, Lenox RH (1991): Receptor coupling to G proteins: Interactions not affected by lithium. Lithium 2:141-147
36. Fichsel H, Knöpfle G (1978): Effects of anticonvulsant drugs on thyroid hormones in epileptic children. Epilepsy 19:323-336
37. Franklyn JA, Davis JRE, Ramsden DB Sheppard MC (1985): Phenytoin and thyroid hormone action. J Endocrinol 104:201-204
38. Gani D, Downes CP, Batty I, Bramham J (1993): Lithium and myo-inositol homeostatis. Biochem Biophys. Acta 1177:253-269
39. Glowinski I, Iversen LL (1966): Regional studies of catecholamine metabolism in the rat brain. I. The disposition of [3H] dopamine and [3H] dopa in various regions of the brain. J Neurochem 13:655-669
40. Hall RC, Stickney S, Baerrisford TP (1986): Endocrine disease and behaviour. Integ Psychiatry 4:122-133
41. Hashimoto H, Walker CH, Prange AJ, Mason GA (1991): The effects of thyroid hormones on potassium-stimulated release of 3H-GABA by synaptosomes of rat cerebral cortex. Neuropsychopharmacology 5:49-54
42. Hatterer JA, Kocsis JH, Stokes PE (1988): Thyroid function in patients maintained on lithium. Psychiatry Res 26:249-257
43. Heal DJ, Smith SL (1988): The effects of acute and repeated administration of T3 to mice on 5-HT1 and 5-HT2 function in the brain and its influence on the actions of repeated electroconvulsive shock. Neuropharmacology 27:1239-1248
44. Herman R, Obarzanek E, Mikalauskas KM, Post RM, Jimerson DC (1991): The effects of carbamazepine on resting metabolic rate and thyroid function in depressed patients. Biol Psychiatry 29:779-788
45. Honchar MP, Ackermann KE, Sherman WR (1989): Chronically administered lithium alters neither myo-inositol monophosphatase activity nor phosphoinositide levels in rat brain. J Neurochem 53:590-594
46. Isojärvi JIT, Pakarinen AJ, Myllylä VV (1992): Thyroid function with antiepileptic drugs. Epilepsia 33:142-148
47. Joffe RT, Singer W (1990): A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Res 32:241-251
48. Jope RS, Song L, Kolasa K (1992): Inositol trisphosphate, cyclic AMP, and cyclic GMP in rat brain regions after lithium and seizures. Biol Psychiatry 31:505-514
49. Jope RS, Williams MB (1994): Lithium and brain signal transduction systems. Biochem Pharmacol 47:429-441
50. Kaplan MM, Utiger RD (1978): lodothyronine metabolism in rat liver homogenates. J Clin Invest 61:459-471
51. Kaplan MM, Yaskoski K (1980): A Phenolic and tyrosol ring deiodination of iodothyronines in rat brain homogenates. J Clin Invest 66:551-562
52. Kendall DA, Whitworth P (1990): Lithium amplifies inhibitions of inositol phospholipid hydrolysis in mammalian brain slices. Br J Pharmacol 100:723-728
53. Klemfuss H (1992): Rhythms and the pharmacology of lithium. Pharmacol Ther 56:53-78
54. Köhrle J, Hesch D, Leonard JL (1991): Intracellular pathways of iodothyronine metabolism. In Bravemann LE, Utiger RD (eds), The Thyroid. Philadelphia, Lippincott, pp 144-189
55. Kripke DF, Whyborney VG (1980): Lithium slows rat circadian activity rhythms. Life Sci 26:1319-1321
56. Kushner JP, Wartofsky L (1988): Lithium-thyroid interactions. In Johnson FN (ed), Lithium and the Endocrine System. Basel, Munchen, Karger, pp 74-98
57. Leonard JL, Rosenberg IN (1980): lodothyronine 5′-deiodinase from rat kidney: Substrate specificity and the 5′deiodination of reverse triiodothyronine. Endocrinology 107:1376-1383
58. MacDonald RL, McLean MJ (1986): Anticonvulsant drugs: Mechanisms of action. Adv Neurol 44:713-736
59. MacDonald RL (1989): Antiepileptic drug actions. Epilepsia 30 (Suppl. 1): 519-528
60. Manji HK, Lenox RH (1994): Long-term action of lithium: A role for transcriptional and posttranscriptional factors regulated by protein kinase C. Synapse 16:11-28
61. 3) binding in rat hepatic nuclear T3 receptors. Endocrinology 112(5):1723-1731
62. Mann DN, Kumara-Siri MH, Surks MI (1983): Effect of 5,5′diphenylhydantoin on the activities on hepatic cytosol malic enzyme and mitochondrial a-glycerophosphate dehydrogenase in athyreotic rats. Endocrinology 112(5):1732-1738
63. Männistö PT (1974): Effect of lithium on deiodinating activity of various rat tissues in vitro. Acta Endocrinol 76:260-272
64. Masana MI, Bitran JA, Hsiao JK, Mefford IN, Potter WZ (1991): Lithium effects on noradrenergic-linked adenylate cyclase activity in intact rat brain: An in vivo microdialysis study. Brain Res 538:333-336
65. Mason GA, Walker CH, Prange AJ Jr, Bondy SC (1987): GABA uptake is inhibited by thyroid hormones: Implications for depression. Psychoneuroendocrinology 12:53-59
66. Mason GA, Walker CH, Prange AJ Jr (1990): Depolarization-dependent 45Ca uptake by synaptosomes of rat cerebral cortex is enhanced by L-triiodothyronine. Neuropsychopharmacology 3:291-295
67. McEachron DL, Kripke DF, Hawkins R, Haus E, Pavlinac D, Deftos L (1982): Lithium delays biochemical circadian rhythms in rats. Neuropsychobiology 8:12-29
68. Meinhold H (1986): Radioimmunoassay of iodothyronines. In Henneman G (ed), Thyroid Hormone Metabolism. New York, Marcel Dekker, pp. 133-186
69. Mendel CM, Weisiger RA, Cavalieri RR (1988): Uptake of 3,5,3′-triiodothyronine by the perfused rat liver: Return to the free hormone hypothesis. Endocrinology 123:1817-1824
70. Michel-Reher MB, Gross G, Jasper JR, Bernstein D, Olbricht T, Brodde O-E, Michel MC (1993): Tissue-and subunitspecific regulation of G-protein expression by hypo-and hyperthyroidism. Biochem Pharmacol 45:1417-1423
71. Mørk A, Geisler A (1989): Effects of lithium ex vivo on the GTP-mediated inhibition of calcium-stimulated adenylate cyclase activity in rat brain. Eur J Pharmacol 168:347-354
72. Newman M, Klein E, Birmaher B, Feinsod M, Belmaker RH (1983): Lithium at therapeutic concentrations inhibits human brain nonadrenaline-sensitive cyclic AMP accumulation. Brain Res 278:380-381
73. Newman ME, Shapira B, Lerer B (1991): Effects of lithium and desimipramine on second messenger responses in rat hippocampus: Relation to G protein effects. Neuropharmacology 30:1297-1301
74. Oppenheimer JJ, Tavernetti RR (1962): Studies on the thyroxine-diphenylhydantoin interaction: Effect of 5,5′-diphenylhydantoin on the displacement of L-thyroxine from thyroxine-binding globulin (TBG). Endocrinology 71:496-504
75. Post RM (1987): Mechanism of action of carbamazepine and related anticonvulsants in affective illness. In Meltzer HY (ed), Psychopharmacology: The Third Generation of Progress. New York, Raven Press, pp 567-576
76. Post RM, Weiss SRB (1994): The neurobiology of treatment-resistant mood disorders. In Bloom FE, Kupfer DJ (eds), Psychopharmacology. The Fourth Generation of Progress. New York, Raven Press, pp 1155-1170
77. Prange AJ Jr, Wilson IC, Rabon AM, Lipton MA (1969): Enhancement of imipramine antidepressant activity by thyroid hormone. Am J Psychiatry 126:457-469
78. Raasmaja A (1990): Alpal-and -adrenergic receptors in brown adipose tissue and the adrenergic regulation of thyroxine 5′-deiodinase. Acta Physiol Scand 139:7-53
79. Rastogi RB, Singhai RL (1977): Lithium: Modification of behavioral activity and brain biogenic amines in developing hyperthyroid rats. J Pharmacol Exp Ther 201:92-102
80. Roy-Byrne PP, Joffe RT, Uhde TW, Post RM (1984): Carbamazepine and thyroid function in affectively ill patients. Arch Gen Psychiary 41:1150-1153
81. Schmidt BH, Schultz JE (1985): Chronic throxine treatment of rats down-regulates the noradrenergic cyclic AMP generating system in cerebral cortex. J Pharmacol Exp Ther 233:466-472
82. Schöpf J, Lemarchand T (1994): Lithium addition in endogenous depressions resistant to tricyclic antidepressants or related drugs: relation to the status of the pituitary-thyroid axis. Pharmacopsychiatry 27:198-201
83. Schöder-Van der Elst JP, Van der Heide D (1990): Effects of 5,5′-diphenylhydantoin on thyroxine and 3,4,3′-triiodothyronine concentrations in several tissues of the rat. Endocrinology 126(1):186-191
84. Smith PJ, Surks MI (1984): Multiple effects of 5,5′-diphenylhydantoin on the thyroid hormone system. Endocr Rev 5(4):514-524
85. St. Germain DL (1987): Regulatory effect of lithium on thyroxine metabolism in murine neural and anterior pituitary tissue. Endocrinology 120:1430-1438
86. St. Germain DL, Schwartzman RA, Croteau W, Kanamori A, Wang Z, Brown DD, Galton VA (1994): A thyroid hormone-regulated gene in Xenopus laevis encodes a type Hi iodothyronine deiodinase. Proc Natl Acad Sci USA 91:7767-7771
87. Stringer BMJ, Wynford-Thomas D (1982): Importance of maintaining "human" radioimmunoassay kits for use with rat samples. Horm Res 16:392-397
88. 1A receptors and 5-HT uptake sites in rat brain: An autoradiographic analysis. Neuroendocrinology 57:1011-1018
89. Timiras PS, Woodbury DM (1956): Effect on thyroid activity on brain function and brain electrolyte distribution in rats. Endocrinology 58:181-192
90. Visser TJ, Leonard JL, Kaplan MM, Larsen PR (1982): Kinetic evidence suggesting two mechanisms for iodothyronine 5′-deiodination in rat cerebral cortex. Proc Natl Acad Sci USA 79:5080-5084
91. Walz RA, Hewlett AC (1987): Thyroid effects on adenosine 3′,5′-monophosphate levels and adenylate cyclase in cultured neuroblastoma cells. Endocrinology 120:1265-1271
92. Whybrow PC, Prange AJ (1981): A hypothesis of thyroid-catecholamine receptor interaction. Arch Gen Psychiatry 38:106-113
93. Wilkinson M, Joshi M, Werstiuk ES, Seggie J (1987): Lithium and rhythms of beta-adrenergic ([3H]CGP-12177) binding in intact rat retina, pineal gland, and hypothalamus. Biol Psychiatry 22:1191-1200
94. Wood AJ, Goodwin GM (1987): A review of the biochemical and neuropharmacological actions of lithium. Psychol Med 17:579-600
95. Zemel LR, Biezunski DR, Shapiro LE, Surks MI (1988): 5,5′Diphenylhydantoin decreases the entry of 3,5,3′-triiodo-L-thyronine but not L-thyroxine in cultured GH-producing cells. Acta Endocrinol 117:392-398